AU2003226820A1 - Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein - Google Patents

Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein

Info

Publication number
AU2003226820A1
AU2003226820A1 AU2003226820A AU2003226820A AU2003226820A1 AU 2003226820 A1 AU2003226820 A1 AU 2003226820A1 AU 2003226820 A AU2003226820 A AU 2003226820A AU 2003226820 A AU2003226820 A AU 2003226820A AU 2003226820 A1 AU2003226820 A1 AU 2003226820A1
Authority
AU
Australia
Prior art keywords
mrn
inhibitors
binding
identification
hur protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003226820A
Other languages
English (en)
Other versions
AU2003226820A8 (en
Inventor
Manfred Auer
Nicole-Claudia Meisner
Volker Uhl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2003226820A8 publication Critical patent/AU2003226820A8/xx
Publication of AU2003226820A1 publication Critical patent/AU2003226820A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003226820A 2002-04-17 2003-04-16 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein Abandoned AU2003226820A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37320702P 2002-04-17 2002-04-17
US60/373,207 2002-04-17
PCT/EP2003/004008 WO2003087815A2 (en) 2002-04-17 2003-04-16 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein

Publications (2)

Publication Number Publication Date
AU2003226820A8 AU2003226820A8 (en) 2003-10-27
AU2003226820A1 true AU2003226820A1 (en) 2003-10-27

Family

ID=29250994

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003226820A Abandoned AU2003226820A1 (en) 2002-04-17 2003-04-16 Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein

Country Status (5)

Country Link
US (1) US7399583B2 (enExample)
EP (1) EP1497327A2 (enExample)
JP (1) JP2005529590A (enExample)
AU (1) AU2003226820A1 (enExample)
WO (1) WO2003087815A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8460864B2 (en) 2003-01-21 2013-06-11 Ptc Therapeutics, Inc. Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
US9068234B2 (en) 2003-01-21 2015-06-30 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating gene expression
US8426194B2 (en) 2003-01-21 2013-04-23 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating VEGF expression
DE10353803A1 (de) * 2003-11-14 2005-06-23 Oligene Gmbh Diagnostische, prognostische und therapeutische Verfahren bei der Untersuchung und Therapie maligner Tumoren
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
SG184755A1 (en) 2004-03-15 2012-10-30 Ptc Therapeutics Inc Carboline derivatives useful in the inhibition of angiogenesis
US7767689B2 (en) 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
US20090005419A1 (en) * 2005-03-03 2009-01-01 Manfred Auer Organic Compounds
US8283115B1 (en) 2007-06-20 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation
US8283116B1 (en) 2007-06-22 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
KR20100012714A (ko) * 2008-07-29 2010-02-08 재단법인서울대학교산학협력재단 Ｒｎａ 분자와 단백질 사이의 상호작용을 조절하는 물질을동정하기 위한 분석 방법
US20100209341A1 (en) 2009-02-18 2010-08-19 Csl Limited Treatment of chronic inflammatory conditions
KR20130032866A (ko) * 2010-02-18 2013-04-02 더 유니버시티 오브 멜버른 만성 염증 상태의 치료
US8822663B2 (en) 2010-08-06 2014-09-02 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
CA2821992A1 (en) 2010-10-01 2012-04-05 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
DE12722942T1 (de) 2011-03-31 2021-09-30 Modernatx, Inc. Freisetzung und formulierung von manipulierten nukleinsäuren
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
HRP20220250T1 (hr) 2011-10-03 2022-04-29 Modernatx, Inc. Modificirani nukleozidi, nukleotidi i nukleinske kiseline, te njihove uporabe
SI2791160T1 (sl) 2011-12-16 2022-07-29 Modernatx, Inc. Sestave modificirane MRNA
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
AU2013243952A1 (en) 2012-04-02 2014-10-30 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
SMT202200337T1 (it) 2012-11-26 2022-09-14 Modernatx Inc Rna modificato al livello del terminale
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
US10023626B2 (en) 2013-09-30 2018-07-17 Modernatx, Inc. Polynucleotides encoding immune modulating polypeptides
US10323076B2 (en) 2013-10-03 2019-06-18 Modernatx, Inc. Polynucleotides encoding low density lipoprotein receptor
CN117448332B (zh) * 2023-08-07 2025-06-24 大连理工大学 一种利用RNA结合蛋白增强mRNA蛋白表达的序列优化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444149A (en) * 1992-05-11 1995-08-22 Duke University Methods and compositions useful in the recognition, binding and expression of ribonucleic acids involved in cell growth, neoplasia and immunoregulation
US5733728A (en) * 1995-08-18 1998-03-31 Regents Of The University Of Colorado Detecting and treating heart failure
US6107029A (en) 1996-07-31 2000-08-22 Message Pharmaceticals, Inc. Universal method for detecting interactions between RNA molecules and RNA binding proteins
US6180604B1 (en) * 1996-08-21 2001-01-30 Micrologix Biotech Inc. Compositions and methods for treating infections using analogues of indolicidin
WO1998039484A1 (en) 1997-03-05 1998-09-11 Scriptgen Pharmaceuticals, Inc. Screen employing fluorescence anisotropy to identify compounds with affinity for nucleic acids
CA2229449A1 (en) * 1997-04-25 1998-10-25 Takeda Chemical Industries, Ltd. Novel receptor protein and its use
JP3793624B2 (ja) * 1997-06-24 2006-07-05 株式会社リコー 回転型現像装置
AU766146B2 (en) 1998-05-26 2003-10-09 University Of Medicine And Dentistry Of New Jersey System for reproducing and modulating stability and turnover of RNA molecules
GB9828709D0 (en) 1998-12-24 1999-02-17 Novartis Ag Assay
ATE275727T1 (de) 1999-04-29 2004-09-15 Coley Pharm Gmbh Screening nach modulatoren der funktion von immunstimulatorischer dna
WO2001012213A2 (en) 1999-08-13 2001-02-22 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Ttp-related zinc finger domains and methods of use
US20020127550A1 (en) 1999-11-10 2002-09-12 Anthony Giordano Nucleic acid sequences and methods for identifying compounds that affect rna/rna binding protein interactions and mrna functionality
AUPQ483599A0 (en) 1999-12-23 2000-02-03 University Of Western Australia, The Mrna binding motif
US20040023231A1 (en) 2000-04-12 2004-02-05 Abu-Khabar Khalid S. System for identifying and analyzing expression of are-containing genes
GB2370273A (en) * 2000-12-20 2002-06-26 Viaxxel Biotech Gmbh Compounds that affect CD83 expression

Also Published As

Publication number Publication date
US7399583B2 (en) 2008-07-15
EP1497327A2 (en) 2005-01-19
AU2003226820A8 (en) 2003-10-27
WO2003087815A3 (en) 2004-09-23
WO2003087815A2 (en) 2003-10-23
JP2005529590A (ja) 2005-10-06
US20060008802A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
AU2003226820A1 (en) Method for the identification of inhibitors of the binding of are-containing mrn a and an hur protein
AU2003237884A1 (en) Method and device for anastomoses
AU2003202026A1 (en) Method for isolating nucleic acids and protein from a single sample
AU2003231847A1 (en) Positive identification system and method
AU2003243646A1 (en) System and method for facilitating ridesharing
AU2003291692A1 (en) Method for assessing fit and alignment of a manufactured part
AU2003217337A1 (en) High-throughput cell identification and isolation method and apparatus
AU2003302532A1 (en) System and method for automated electronic device design
AU2003269671A1 (en) Method and apparatus for palmprint identification
AU2003270735A1 (en) System and method for removing material
AU2003266616A1 (en) Test system and control method thereof
AU2003233705A1 (en) Method and apparatus for identifying gemstones
AU2003216671A1 (en) Device and method for storing information
AU2003291081A1 (en) Identification apparatus and method
AU2003300530A1 (en) Dhodh-inhibitors and method for their identification
AU2002338428A1 (en) Methods and systems for identifying proteins
AU2002345287A1 (en) Peptide and protein identification method
AU2003273841A1 (en) Method for identifying bhs-specific proteins and fragments thereof
AU2003260534A1 (en) Method and apparatus for determining hysteresis
AU2002367604A1 (en) Apparatus and method for designing proteins and protein libraries
AU2003234767A1 (en) Multi-medium information providing system and multi-medium information providing method
AU2003266371A1 (en) Method for the analysis and modification of a footprint
AU2003263271A1 (en) Method capable of being automated for detection of prpless thanspgreater thanresless than/spgreater than and uses thereof
IL169331A0 (en) Apparatus and method for storing proteins
AU2003242917A1 (en) Motor-kinetic identification apparatus and method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase